Circulating cytokines associated with clinical outcomes in advanced non-small cell lung cancer patients who received chemoimmunotherapy.
Yuequan ShiXiaoyan LiuJuan DuDongming ZhangJia LiuMin-Jiang ChenJing ZhaoWei ZhongYan XuMengzhao WangPublished in: Thoracic cancer (2021)
In patients with advanced NSCLC who received chemoimmunotherapy, on-treatment increased IL-1β and IFN-γ may serve as positive indicator of efficacy, while on-treatment increased IL-6 might play a predictive role of worse clinical outcome.